---
figid: PMC6905468__nihms-1543226-f0008
figlink: pmc/articles/PMC6905468/figure/F8/
number: Figure 8
caption: Under normal conditions, cisplatin-DNA adducts (indicated by G<>G) are removed
  by the NER machinery, ATR becomes activated, and the excision gap can be filled
  in by DNA synthesis and ligation. However, when ATR kinase is inhibited, the gap
  filling process becomes more dependent on the translesion synthesis (TLS) pathway,
  which can result in mutagenesis or cell death.
pmcid: PMC6905468
papertitle: ATR kinase inhibition sensitizes quiescent human cells to the lethal effects
  of cisplatin but increases mutagenesis.
reftext: Rebekah J. Hutcherson, et al. Mutat Res. ;816-818:111678-111678.
pmc_ranked_result_index: '38858'
pathway_score: 0.8507243
filename: nihms-1543226-f0008.jpg
figtitle: Schematic summarizing the effect of ATR kinase inhibition in cisplatin-treated
  quiescent cells
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6905468__nihms-1543226-f0008.html
  '@type': Dataset
  description: Under normal conditions, cisplatin-DNA adducts (indicated by G<>G)
    are removed by the NER machinery, ATR becomes activated, and the excision gap
    can be filled in by DNA synthesis and ligation. However, when ATR kinase is inhibited,
    the gap filling process becomes more dependent on the translesion synthesis (TLS)
    pathway, which can result in mutagenesis or cell death.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PCNA
  - RPA1
  - RPA2
  - RPA3
  - ATRIP
  - ATR
  - FUS
genes:
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA1
  entrez: '6117'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA2
  entrez: '6118'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA3
  entrez: '6119'
- word: ATRIP
  symbol: ATRIP
  source: hgnc_symbol
  hgnc_symbol: ATRIP
  entrez: '84126'
- word: ATR/
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA1
  entrez: '6117'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA2
  entrez: '6118'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA3
  entrez: '6119'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA1
  entrez: '6117'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA2
  entrez: '6118'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA3
  entrez: '6119'
- word: TLS
  symbol: TLS
  source: hgnc_alias_symbol
  hgnc_symbol: FUS
  entrez: '2521'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA1
  entrez: '6117'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA2
  entrez: '6118'
- word: RPA
  symbol: RPA
  source: bioentities_symbol
  hgnc_symbol: RPA3
  entrez: '6119'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
chemicals: []
diseases: []
---
